Consensus for 2025 revenue is $369.52M. Still sees adjusted net income positive each quarter and for full year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx reports Q2 adjusted EPS 50c, consensus 11c
- GeneDx Holdings: Strong Market Position and Growth Potential in Rare Disease Testing
- GeneDx initiated with an Overweight at Piper Sandler
- GeneDx price target raised to $115 from $88 at Guggenheim
- GeneDx announces SeqFirst study data on rapid genomic testing in pediatrics